VCH 916

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VCH 916, covering 2014-04-04 to 2014-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection [Phase 1]

See pricing